Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, June 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 110 articles:
HTML format


 

Single Articles

  1. GALLAS S, Knaz H, Methnani J, Maatallah Kanzali M, et al
    Prevalence and risk factors of functional gastrointestinal disorders in early period medical students: a pilot study in Tunisia.
    Libyan J Med. 2022;17:2082029.
    PubMed    
    Abstract available

  2. PFANZAGL B, Pfragner R, Jensen-Jarolim E
    Histamine via histamine H1 receptor enhances the muscarinic receptor-induced calcium response to acetylcholine in an enterochromaffin cell model.
    Clin Exp Pharmacol Physiol. 2022 Jun 2. doi: 10.1111/1440-1681.13682.
    PubMed    
    Abstract available

  3. TANG Y, Chen L, Liu B, Sun P, et al
    Spinal P2X4 Receptors Involved in Visceral Hypersensitivity of Neonatal Maternal Separation Rats.
    Purinergic Signal. 2022 Jun 1. pii: 10.1007/s11302-022-09868.
    PubMed    
    Abstract available

  4. JUNG KW, Myung SJ
    An Asian perspective on irritable bowel syndrome.
    Intest Res. 2022 May 31. pii: ir.2021.00136. doi: 10.5217/ir.2021.00136.
    PubMed    
    Abstract available

  5. LIMA PA, Berg BB, Castor MGME
    Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies.
    Intest Res. 2022 May 31. pii: ir.2021.00160. doi: 10.5217/ir.2021.00160.
    PubMed    
    Abstract available

  6. KUTSCHKE J, Harris JR, Bengtson MB
    The relationships between IBS and perceptions of physical and mental health-a Norwegian twin study.
    BMC Gastroenterol. 2022;22:266.
    PubMed    
    Abstract available

  7. LATENSTEIN CSS, de Reuver PR
    Tailoring diagnosis and treatment in symptomatic gallstone disease.
    Br J Surg. 2022 May 31. pii: 6595861. doi: 10.1093.
    PubMed    
    Abstract available

  8. CHEN J, Zhang Y, Barandouzi ZA, Lee J, et al
    The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: A randomized controlled trial.
    Int J Nurs Stud. 2022;132:104278.
    PubMed    
    Abstract available

  9. LABUS JS, Wang C, Mayer EA, Gupta A, et al
    Sex-specific brain microstructural reorganization in irritable bowel syndrome.
    Pain. 2022 May 25. pii: 00006396-990000000-00108.
    PubMed    
    Abstract available

  10. MANNING LP, Tuck CJ, Biesiekierski JR
    The lived experience of irritable bowel syndrome: A focus on dietary management.
    Aust J Gen Pract. 2022;51:395-400.
    PubMed    
    Abstract available

  11. MAGDY R, Eid RA, Hassan M, Abdelghaffar M, et al
    The potential impact of nutritional intake on symptoms severity in patients with comorbid migraine and irritable bowel syndrome.
    BMC Neurol. 2022;22:199.
    PubMed    
    Abstract available

  12. COCKRUM R, Tu F
    Hysterectomy for Chronic Pelvic Pain.
    Obstet Gynecol Clin North Am. 2022;49:257-271.
    PubMed    
    Abstract available

  13. BAUMANN-DURCHSCHEIN F, Furst S, Hammer HF
    Practical application of breath tests in disorders of gut-brain interaction.
    Curr Opin Pharmacol. 2022;65:102244.
    PubMed    
    Abstract available

  14. YASUDA R, Kamada K, Murakami T, Inoue R, et al
    Astaxanthin attenuated the stress-induced intestinal motility disorder via altering the gut microbiota.
    Int J Vitam Nutr Res. 2022 May 30. doi: 10.1024/0300-9831/a000756.
    PubMed    
    Abstract available

  15. OH H, Ehrenpreis ED, Tu FF, Dillane KE, et al
    Menstrual Cycle Variation in MRI-Based Quantification of Intraluminal Gas in Women With and Without Dysmenorrhea.
    Front Pain Res (Lausanne). 2022;3:720141.
    PubMed    
    Abstract available

  16. JI M, Huang H, Lan X
    Correlation between Intestinal Microflora in Irritable Bowel Syndrome and Severity.
    Dis Markers. 2022;2022:1031844.
    PubMed    
    Abstract available

  17. YE Y, Liu Y, Cheng K, Wu Z, et al
    Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides.
    Front Nutr. 2022;9:810453.
    PubMed    
    Abstract available

  18. ARESKOUG SANDBERG E, Duberg A, Lorenzon Fagerberg U, Morelius E, et al
    Saliva Cortisol in Girls With Functional Abdominal Pain Disorders: A Randomized Controlled Dance and Yoga Intervention.
    Front Pediatr. 2022;10:836406.
    PubMed    
    Abstract available

  19. WANG X, Gao S, Yun S, Zhang M, et al
    Microencapsulating Alginate-Based Polymers for Probiotics Delivery Systems and Their Application.
    Pharmaceuticals (Basel). 2022;15.
    PubMed    
    Abstract available

  20. PENG Z, Yi J, Liu X
    A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  21. SCHNEDL WJ, Meier-Allard N, Michaelis S, Lackner S, et al
    Serum Diamine Oxidase Values, Indicating Histamine Intolerance, Influence Lactose Tolerance Breath Test Results.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  22. JUNG K, Kim A, Lee JH, Cho D, et al
    Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1(TM)) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  23. MISHIMA T, Fujioka S, Kawazoe M, Inoue K, et al
    Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  24. NEGUSSIE AB, Dell AC, Davis BA, Geibel JP, et al
    Colonic Fluid and Electrolyte Transport 2022: An Update.
    Cells. 2022;11.
    PubMed    
    Abstract available

  25. SALVO-ROMERO E, Rodino-Janeiro BK, Albert-Bayo M, Lobo B, et al
    Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction.
    Cells. 2022;11.
    PubMed    
    Abstract available

  26. OKAZAKI Y, Yoshida S, Kashima S, Miyamori D, et al
    Increased prescriptions for irritable bowel syndrome after the 2018 Japan Floods: a longitudinal analysis based on the Japanese National Database of Health Insurance Claims and Specific Health Checkups.
    BMC Gastroenterol. 2022;22:263.
    PubMed    
    Abstract available

  27. UPADHYAY A, Sundaria N, Dhiman R, Prajapati VK, et al
    Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges.
    Neuroscientist. 2022;28:271-282.
    PubMed    
    Abstract available

  28. EMRE E, Tazegul G, Akin M
    Rome IV Criteria-Defined Irritable Bowel Syndrome in Atopic Patients and the Effect of Anxiety and Depression: A Case-Control Study.
    Turk J Gastroenterol. 2022;33:397-405.
    PubMed    
    Abstract available

  29. BU Z, Ye X, Huang B, Liu R, et al
    Bifidobacteria Was Decreased in Adult Patients With Irritable Bowel Syndrome Based on PCR and Bacterial Culture: A Systematic Review and Meta-Analysis.
    Turk J Gastroenterol. 2022;33:368-376.
    PubMed    
    Abstract available

  30. CHENG L, Luo QQ, Chen SL
    Expression of TRP Channels in Colonic Mucosa of IBS-D Patients and Its Correlation with the Severity of the Disease.
    Gastroenterol Res Pract. 2022;2022:7294775.
    PubMed    
    Abstract available

  31. RAY J, LaBundy J
    Lower Gastrointestinal Tract Disorders: Clinical Updates in Women's Health Care Primary and Preventive Care Review.
    Obstet Gynecol. 2022;139:1201.
    PubMed    
    Abstract available

  32. BAKER JR, Curtin BF, Moshiree B, Rao SSC, et al
    Organizing and Developing a GI Motility Lab in Community Practice: Challenges and Rewards.
    Curr Gastroenterol Rep. 2022 Jun 8. pii: 10.1007/s11894-022-00838.
    PubMed    
    Abstract available

  33. DECRAECKER L, Boeckxstaens G, Denadai-Souza A
    Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS.
    Front Physiol. 2022;13:880422.
    PubMed    
    Abstract available

  34. JUN H, Ko SJ, Kim K, Kim J, et al
    An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome.
    Front Pharmacol. 2022;13:894122.
    PubMed    
    Abstract available

  35. RURGO S, Vaino V, Andreozzi M, Pagliaro M, et al
    Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome.
    J Basic Clin Physiol Pharmacol. 2022 Jun 6. pii: jbcpp-2022-0081.
    PubMed    
    Abstract available

  36. SVENSSON A, Garcia-Etxebarria K, Akesson A, Borgfeldt C, et al
    Applicability of polygenic risk scores in endometriosis clinical presentation.
    BMC Womens Health. 2022;22:208.
    PubMed    
    Abstract available


  37. Tenapanor (Ibsrela) for irritable bowel syndrome with constipation.
    Med Lett Drugs Ther. 2022;64:91-94.
    PubMed    


  38. MOCCI E, Goto T, Chen J, Ament S, et al
    Early and Late Transcriptional Changes in Blood, Neural, and Colon Tissues in Rat Models of Stress-Induced and Comorbid Pain Hypersensitivity Reveal Regulatory Roles in Neurological Disease.
    Front Pain Res (Lausanne). 2022;3:886042.
    PubMed    
    Abstract available

  39. HUANG ST, Chen BB, Song ZJ, Tang HL, et al
    Unraveling the role of Epac1-SOCS3 signaling in the development of neonatal-CRD-induced visceral hypersensitivity in rats.
    CNS Neurosci Ther. 2022 Jun 15. doi: 10.1111/cns.13880.
    PubMed    
    Abstract available

  40. MIRYAN M, Soleimani D, Alavinejad P, Abbaspour M, et al
    Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS-C) and mixed (IBS-M) stool pattern: A randomized, double-blind clinical trial.
    Food Sci Nutr. 2022;10:1899-1907.
    PubMed    
    Abstract available

  41. LOWE B, Nestoriuc Y, Andresen V, Vettorazzi E, et al
    Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT).
    BMJ Open. 2022;12:e059529.
    PubMed    
    Abstract available

  42. YEPEZ D, Grandes XA, Talanki Manjunatha R, Habib S, et al
    Fibromyalgia and Depression: A Literature Review of Their Shared Aspects.
    Cureus. 2022;14:e24909.
    PubMed    
    Abstract available

  43. SAVARINO E, Zingone F, Barberio B, Marasco G, et al
    Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.
    United European Gastroenterol J. 2022 Jun 13. doi: 10.1002/ueg2.12259.
    PubMed    
    Abstract available

  44. CIPCIC PALJETAK H, Baresic A, Panek M, Peric M, et al
    Gut microbiota in mucosa and feces of newly diagnosed, treatment-naive adult inflammatory bowel disease and irritable bowel syndrome patients.
    Gut Microbes. 2022;14:2083419.
    PubMed    
    Abstract available

  45. CIRIZA DE LOS RIOS C, Aparicio Cabezudo M, Zatarain Valles A, Rey E, et al
    Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet.
    Rev Esp Enferm Dig. 2022;114.
    PubMed    
    Abstract available

  46. SALANSKI P, Kowalczyk M, Bardowski JK, Szczepankowska AK, et al
    Health-Promoting Nature of Lactococcus lactis IBB109 and Lactococcus lactis IBB417 Strains Exhibiting Proliferation Inhibition and Stimulation of Interleukin-18 Expression in Colorectal Cancer Cells.
    Front Microbiol. 2022;13:822912.
    PubMed    
    Abstract available

  47. LEE W, Wong JK, Ilhan E, Raj SR, et al
    Iatrogenic Arteriovenous Fistula: A Rare Complication of Pacemaker Implantation.
    JACC Case Rep. 2022;4:402-405.
    PubMed    
    Abstract available

  48. GU Y, Wang C, Qin X, Zhou B, et al
    Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota.
    Pharmacol Res. 2022;181:106291.
    PubMed    
    Abstract available

  49. COONEY J, Poullis A
    Post-COVID-19 irritable bowel syndrome.
    Neurogastroenterol Motil. 2022 Jun 11:e14420. doi: 10.1111/nmo.14420.
    PubMed    


  50. KIM H, Oh Y, Chang SJ
    Internet-Delivered Cognitive Behavioral Therapy in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.
    J Med Internet Res. 2022;24:e35260.
    PubMed    
    Abstract available

  51. KARPE AV, Liu JW, Shah A, Koloski N, et al
    Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS).
    Metabolomics. 2022;18:38.
    PubMed    
    Abstract available

  52. CHEN J, Zhang Y, Barandouzi ZA, Xu W, et al
    Somatosensory Profiles Differentiate Pain and Psychophysiological Symptoms Among Young Adults With Irritable Bowel Syndrome: A Cluster Analysis.
    Clin J Pain. 2022;38:492-501.
    PubMed    
    Abstract available

  53. STRISCIUGLIO C, Cenni S, Serra MR, Dolce P, et al
    Diet and Pediatric Functional Gastrointestinal Disorders in Mediterranean Countries.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  54. SPECKMANN B, Kleinbolting J, Borner F, Jordan PM, et al
    Synbiotic Compositions of Bacillus megaterium and Polyunsaturated Fatty Acid Salt Enable Self-Sufficient Production of Specialized Pro-Resolving Mediators.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  55. EDER P, Kowalski P, Mastalerz-Migas A, Skrzydlo-Radomanska B, et al
    Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners-An Observational, Retrospective, Cross-Sectional Study Using Real-World Data.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  56. MARASCO G, Cremon C, Barbaro MR, Falangone F, et al
    Pathophysiology and Clinical Management of Bile Acid Diarrhea.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  57. WEN L, Tang L, Zhang M, Wang C, et al
    Gallic Acid Alleviates Visceral Pain and Depression via Inhibition of P2X7 Receptor.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  58. LOPEZ-GOMEZ L, Anton J, Lopez-Tofino Y, Pomana B, et al
    Effects of Commercial Probiotics on Colonic Sensitivity after Acute Mucosal Irritation.
    Int J Environ Res Public Health. 2022;19.
    PubMed    
    Abstract available

  59. LAYUNTA E, Forcen R, Grasa L
    TLR2 and TLR4 Modulate Mouse Ileal Motility by the Interaction with Muscarinic and Nicotinic Receptors.
    Cells. 2022;11.
    PubMed    
    Abstract available

  60. HABUS M, Mykolenko S, Ivekovic S, Pastor K, et al
    Bioprocessing of Wheat and Amaranth Bran for the Reduction of Fructan Levels and Application in 3D-Printed Snacks.
    Foods. 2022;11.
    PubMed    
    Abstract available

  61. MAN REK, Fenwick EK, Khadka J, Wu Z, et al
    Psychometric Evaluation of Glaucoma Quality of Life Item Banks (GlauCAT) and Initial Assessment Using Computerized Adaptive Testing.
    Transl Vis Sci Technol. 2022;11:9.
    PubMed    
    Abstract available

  62. KOIZUMI K, Hamaguchi T, Tayama J, Fukudo S, et al
    A Method of Generating a Classifier that Determines the Presence or Absence of IBS Symptoms by Supervised Learning from the Frequency Analysis of Electroencephalogram Data.
    Front Biosci (Landmark Ed). 2022;27:187.
    PubMed    
    Abstract available

  63. MITTAL A, Gupta S, Afridi F, Dimitrey A, et al
    Do Socio-Demographics Play a Role in the Prevalence of Red Flags and Pursuant Colonoscopies in Patients With Irritable Bowel Syndrome?
    Cureus. 2022;14:e25137.
    PubMed    
    Abstract available

  64. GRENDA A, Grenda T, Domaradzki P, Kwiatek K, et al
    Enterococci-Involvement in Pathogenesis and Therapeutic Potential in Cancer Treatment: A Mini-Review.
    Pathogens. 2022;11.
    PubMed    
    Abstract available

  65. SHANG X, E FF, Guo KL, Li YF, et al
    Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  66. ALEXANDRU BA, Rat LA, Moldovan AF, Mihancea P, et al
    An Open-Label Trial Study of Quality-of-Life Assessment in Irritable Bowel Syndrome and Their Treatment.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  67. KUMEI S, Ishioh M, Murakami Y, Ando K, et al
    A patient with familial Mediterranean fever mimicking diarrhea-dominant irritable bowel syndrome who successfully responded to treatment with colchicine: a case report.
    J Med Case Rep. 2022;16:247.
    PubMed    
    Abstract available

  68. ROBBERTZ AS, Cohen LL, Armistead LP, Reed B, et al
    Pandemic-Related Social Disruption and Well-Being in Pediatric Gastrointestinal Diseases.
    J Pediatr Psychol. 2022 Jun 22. pii: 6613068. doi: 10.1093.
    PubMed    
    Abstract available

  69. SO D, Loughman A, Staudacher HM
    Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis.
    Am J Clin Nutr. 2022 Jun 21. pii: 6612725. doi: 10.1093.
    PubMed    
    Abstract available

  70. LAROUTE V, Beaufrand C, Gomes P, Nouaille S, et al
    Lactococcus lactis NCDO2118 exerts visceral antinociceptive properties in rat via GABA production in the gastro-intestinal tract.
    Elife. 2022;11.
    PubMed    
    Abstract available

  71. MELCHIOR C, Algera J, Colomier E, Tornblom H, et al
    Irritable bowel syndrome with food-related symptoms: Future directions in the clinical management.
    United European Gastroenterol J. 2022 Jun 21. doi: 10.1002/ueg2.12265.
    PubMed    
    Abstract available

  72. WANG L, Song C, Wang Y, Hu L, et al
    Symptoms Compatible with Rome IV Functional Bowel Disorder in Patients with Ankylosing Spondylitis.
    Mod Rheumatol. 2022 Jun 21. pii: 6612220. doi: 10.1093.
    PubMed    
    Abstract available

  73. CHOO C, Mahurkar-Joshi S, Dong TS, Lenhart A, et al
    Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
    Am J Physiol Gastrointest Liver Physiol. 2022.
    PubMed    
    Abstract available

  74. ROMANAZZO S, Mansueto G, Cosci F
    Anxiety in the Medically Ill: A Systematic Review of the Literature.
    Front Psychiatry. 2022;13:873126.
    PubMed    
    Abstract available

  75. KIM HY, Park ES, Choi YS, Park SJ, et al
    Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study.
    Food Nutr Res. 2022;66.
    PubMed    
    Abstract available

  76. CEULEERS H, Hanning N, De Bruyn M, De Man JG, et al
    The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult.
    Front Pharmacol. 2022;13:765744.
    PubMed    
    Abstract available

  77. ZHAO HJ, Zhang XJ, Zhang NN, Yan B, et al
    Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Front Nutr. 2022;9:890357.
    PubMed    
    Abstract available

  78. WEI L, Singh R, Ghoshal UC
    Enterochromaffin Cells-Gut Microbiota Crosstalk: Underpinning the Symptoms, Pathogenesis, and Pharmacotherapy in Disorders of Gut-Brain Interaction.
    J Neurogastroenterol Motil. 2022 Jun 20. pii: jnm22008. doi: 10.5056/jnm22008.
    PubMed    
    Abstract available

  79. PETERS M, Mikeltadze I, Karro H, Saare M, et al
    Endometriosis and irritable bowel syndrome: similarities and differences in the spectrum of comorbidities.
    Hum Reprod. 2022 Jun 17. pii: 6609839. doi: 10.1093.
    PubMed    
    Abstract available

  80. ZHU SS, Wang JJ, Zou L, Chen JY, et al
    [Anti-inflammation effect of moxibustion for rats with diarrhea-predominant irritable bowel syndrome based on multiple miRNAs regulating NF-kappaB signal pathway].
    Zhongguo Zhen Jiu. 2022;42:654-62.
    PubMed    
    Abstract available

  81. MAHLER T, Hoffman I, Smets F, Vandenplas Y, et al
    The Belgian consensus on irritable bowel syndrome: the paediatric gastroenterologist view.
    Acta Gastroenterol Belg. 2022;85:384-386.
    PubMed    


  82. KINDT S, Louis H, Deschepper H, Arts J, et al
    Belgian consensus on irritable bowel syndrome.
    Acta Gastroenterol Belg. 2022;85:360-382.
    PubMed    
    Abstract available

  83. VANUYTSEL T, Reenaers C
    Essential reading from the editor's desk.
    Acta Gastroenterol Belg. 2022;85:255-256.
    PubMed    


  84. CID-RUZAFA J, Lacy BE, Schultze A, Duong M, et al
    Linaclotide utilization and potential for off-label use and misuse in three European countries.
    Therap Adv Gastroenterol. 2022;15:17562848221100946.
    PubMed    
    Abstract available

  85. SOLOV'EVA TF, Bakholdina SI, Khomenko VA, Sidorin EV, et al
    Expression of membrane beta-barrel protein in E. coli at low temperatures: Structure of Yersinia pseudotuberculosis OmpF porin inclusion bodies.
    Biochim Biophys Acta Biomembr. 2022;1864:183971.
    PubMed    
    Abstract available

  86. TARASCA MV, Naser D, Schaefer A, Soule TG, et al
    Quenched hydrogen-deuterium amide exchange optimization for high-resolution structural analysis of cellular protein aggregates.
    Anal Biochem. 2022;652:114675.
    PubMed    
    Abstract available

  87. RANGAN V, Nee J, Lembo AJ
    Small Intestinal Bacterial Overgrowth Breath Testing in Gastroenterology: Clinical Utility and Pitfalls.
    Clin Gastroenterol Hepatol. 2022;20:1450-1453.
    PubMed    


  88. COFFIN PB, Duboc H
    Diagnostic and therapeutic approach to persistent abdominal pain beyond irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Jun 2. doi: 10.1111/apt.17064.
    PubMed    
    Abstract available

  89. LOVDAHL J, Tornblom H, Ringstrom G, Palsson OS, et al
    Editorial: group-based hypnotherapy as good as individually delivered hypnotherapy for symptoms of irritable bowel syndrome-authors' reply.
    Aliment Pharmacol Ther. 2022;56:160-161.
    PubMed    


  90. MIKOCKA-WALUS A, Lores T
    Editorial: group-based hypnotherapy as good as individually delivered hypnotherapy for symptoms of irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022;56:158-159.
    PubMed    


  91. BIESIEKIERSKI JR, Wu J, Van Oudenhove L
    Letter: gut-brain axis dysfunction underlies symptom generation in irritable bowel syndrome-a plea for rational interpretation of irrational doses of FODMAPs. Authors' reply.
    Aliment Pharmacol Ther. 2022;56:368-369.
    PubMed    


  92. HALMOS EP, Gibson PR
    Letter: gut-brain axis dysfunction underlies symptom generation in irritable bowel syndrome-a plea for rational interpretation of irrational doses of FODMAPs.
    Aliment Pharmacol Ther. 2022;56:366-367.
    PubMed    


  93. CURTIS S, Curtis M
    Tenapanor (Ibsrela) for the Treatment of Irritable Bowel Syndrome With Constipation.
    Am Fam Physician. 2022;105:656-658.
    PubMed    


  94. EBELL MH
    British Society of Gastroenterology Guidelines for the Management of Irritable Bowel Syndrome.
    Am Fam Physician. 2022;105:Online.
    PubMed    


  95. TACK J, Tornblom H, Tan V, Carbone F, et al
    Evidence-Based and Emerging Dietary Approaches to Upper Disorders of Gut-Brain Interaction.
    Am J Gastroenterol. 2022;117:965-972.
    PubMed    
    Abstract available

  96. LACKNER JM, Gudleski GD, Radziwon CD, Krasner SS, et al
    Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education/support.
    Behav Res Ther. 2022;154:104033.
    PubMed    
    Abstract available

  97. WANG T, Rijnaarts I, Hermes GDA, de Roos NM, et al
    Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 May 27. pii: 10.1007/s10620-022-07543.
    PubMed    
    Abstract available

  98. OLMOS JI, Piskorz MM, Litwin N, Schaab S, et al
    Exocrine Pancreatic Insufficiency is Undiagnosed in Some Patients with Diarrhea-Predominant Irritable Bowel Syndrome Using the Rome IV Criteria.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07568.
    PubMed    
    Abstract available

  99. LEE AA, McNabb-Baltar J
    Undiagnosed Exocrine Pancreatic Insufficiency in Diarrhea-Predominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07574.
    PubMed    


  100. LEMBO A, Sultan S, Chang L, Heidelbaugh JJ, et al
    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
    Gastroenterology. 2022;163:137-151.
    PubMed    
    Abstract available

  101. CHANG L, Sultan S, Lembo A, Verne GN, et al
    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
    Gastroenterology. 2022;163:118-136.
    PubMed    
    Abstract available

  102. ZIA JK, Lenhart A, Yang PL, Heitkemper MM, et al
    Risk Factors for Abdominal Pain Disorders of Gut Brain Interaction in Adults and Children: A Systematic Review.
    Gastroenterology. 2022 Jun 15. pii: S0016-5085(22)00646.
    PubMed    
    Abstract available

  103. EL-SALHY M, Winkel R, Casen C, Hausken T, et al
    Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at three years after transplantation.
    Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00625.
    PubMed    
    Abstract available

  104. REJ A, Sanders DS, Aziz I
    Further research needed to determine first-line therapy for IBS in primary care.
    Gut. 2022 Jun 22. pii: gutjnl-2022-328047. doi: 10.1136/gutjnl-2022-328047.
    PubMed    


  105. ZHANG Y, Fu F, Zhang L, Zhang W, et al
    Telomere is Shortened in Patients with Irritable Bowel Syndrome in the Chinese Population.
    J Gastroenterol Hepatol. 2022 Jun 15. doi: 10.1111/jgh.15912.
    PubMed    
    Abstract available

  106. THOMASSEN RA, Luque V, Assa A, Borrelli O, et al
    An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology.
    J Pediatr Gastroenterol Nutr. 2022 Jun 16. pii: 00005176-990000000-00092.
    PubMed    
    Abstract available

  107. TRINDADE IA, Melchior C, Tornblom H, Simren M, et al
    Quality of life in irritable bowel syndrome: Exploring mediating factors through structural equation modelling.
    J Psychosom Res. 2022;159:110809.
    PubMed    
    Abstract available

  108. IVASHKIN VT, Kudryavtseva AV, Krasnov GS, Poluektov YM, et al
    Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.
    PLoS One. 2022;17:e0263880.
    PubMed    
    Abstract available

  109. OZAKA S, Sonoda A, Ariki S, Minata M, et al
    Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
    PLoS One. 2022;17:e0269698.
    PubMed    
    Abstract available

  110. ABID S, Rehman H, Awan S, Artani A, et al
    Epidemiology of functional gastrointestinal disorders using ROME III adult questionnaire, a population based cross sectional study in Karachi-Pakistan.
    PLoS One. 2022;17:e0268403.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;